A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy
Segawa, Y. ; Aogi, K. ; Inoue, K. ; Sano, M. ; Sekine, I. ; Tokuda, Y. ; Isobe, H. ; Ogura, T. ; Tsuboi, M. ; Atagi, S.
Annals of oncology, 2009-11, Vol.20 (11), p.1874-1880 [Periódico revisado por pares]Oxford: Oxford University Press
Texto completo disponível